ORBERA Intragastric Balloon System: payments to doctors
Payments that named ORBERA Intragastric Balloon System as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $550K
- Providers
- 437
- Transactions
- 1,029
- Average per transaction
- $535
The per-transaction average — $535 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 437 providers the average total is $1,259, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Boston Scientific | $376,488 | 68.4% |
| Apollo Endosurgery US Inc | $173,569 | 31.6% |